Medications

Omega-3s may be useful adjunct to opioids in pain therapy

(HealthDay)—Chronic omega-3 fatty acid (O3) supplementation has an additive effect when combined with acute dosages of morphine in an animal model, according to a study published online May 25 in the Journal of Pharmacy ...

Oncology & Cancer

Added corticosteroid deemed ineffective for cancer pain

(HealthDay)—The addition of methylprednisolone (MP) to opioid therapy does not appear to increase the analgesic effect for cancer pain, according to research published online July 7 in the Journal of Clinical Oncology.

Medications

Placebo effects of different therapies not identical

Not all placebos are equal, and patients who respond to one placebo don't always respond to others, according to research published July 31 in the open access journal PLOS ONE by Jian Kong from Massachusetts General Hospital, ...

Psychology & Psychiatry

The nocebo effect: Media reports may trigger symptoms of a disease

Media reports about substances that are supposedly hazardous to health may cause suggestible people to develop symptoms of a disease even though there is no objective reason for doing so. This is the conclusion of a study ...

Medical research

A new promising approach in the therapy of pain

The treatment of inflammatory pain can be improved by endogenous opioid peptides acting directly in injured tissue. Scientists at the Charité – Universitätsmedizin Berlin and the Université Paris Descartes showed that ...

Oncology & Cancer

Adding ketamine to opioids doesn't reduce cancer pain

(HealthDay)—Using subcutaneously administered ketamine in a dose-escalating regimen as an adjunct to opioids and standard co-analgesics does not have any clinical benefit in relieving cancer pain, but it is associated with ...

page 2 from 3